Those with phosphate levels in the highest two quartiles progressed significantly faster either to end-stage renal disease (ESRD) or to a composite endpoint of a doubling of serum creatinine.
Therapeutic options for SIADH have been significantly enhanced with the introduction of specific vasopressin receptor antagonists
Researchers have identified a bidirectional association between renal cell carcinoma (RCC) and multiple myeloma, which suggests that common risk factors influence development of both malignancies, according to a recent report in BJU International.
High levels of bone alkaline phosphatase (BAP) are associated with increased short-term mortality among dialysis patients, a finding that underscores the important impact of bone turnover in this population, investigators reported.
The FDA has approved denosumab (Prolia) as a treatment to increase bone mass in prostate cancer patients at high risk for fracture undergoing androgen deprivation therapy (ADT) and women with breast cancer at high risk for fracture who are receiving aromatase inhibitor therapy.
Erectile dysfunction (ED) can improve the effectiveness of screening diabetic men for asymptomatic coronary artery disease (CAD), according to researchers.